There is renewed interest in neuromodulator/neurotoxins because of 2 newcomers to the US aesthetic market. Jeuveau is FDA approved and Revance will be approved early 2020. To differentiate themselves, these 2 have focused on duration of action of their products. Here’s the lowdown on what patients need to know about these wrinkle eradication injections. […]
Why Dysport is Dr. Weiner’s Favorite Neuromodulator/Neurotoxin
The most popular cosmetic procedure in the world is wrinkle reducing injections with neurotoxins or the friendlier term, neuromodulators. The injections work by reducing the activity of the muscles they are injected to, there by resulting in less movement and less dynamic wrinkles. Static wrinkles, ones that appear at rest, are less affected by these […]
Dr. Steven F. Weiner answers questions about Botox
Q: Shouldn’t 30 units of botox be sufficient for glabellar 11’s? (Photo) A: Movement persists after 30u of Botox – several reasons Someone with a very strong glabella can’t expect to have complete movement cessation with Botox. There is a scale 0-4 and you can expect 1-2 drops in the scale with proper placement and […]
What’s new in Botox Treatments, MicroBotox, and the Upcoming “Botox Cream” by Revance Theraputics
Dr. Weiner answers questions about Botox Botox was originally FDA approved for treating stabismus (lazy eye) and blepharospasm (spasms of the eyelids) in 1989. When treating around the eye, patients and doctors were noting the wrinkles around the eyes were improving and brows were elevating. Studies were then initiated by Drs. Jean and Alastair Carruthers […]
Steven F. Weiner, MD demonstrates the Liquid Facelift
Questions Answered by Dr. Weiner on Radiesse This is Dr. Weiner from The Aesthetic Clinique, demonstrating a Liquid Facelift. A Liquid Facelift is when dermal fillers are used to replace lost volume in the entire face which has occurred due to aging, exercise, and/or weight loss. With no incisions or cutting, you can lift the […]
